CLDX

Celldex Therapeutics, Inc. Analyst PE Estimates

$12.0999
*  
0.2001
  negative  
1.63%
Get CLDX Alerts
*Delayed - data as of May 24, 2013 10:18 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLDX Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
CLDX
Celldex Therapeutics, Inc. NASDAQ-GS


Price/Earning Ratio
Price/Earnings Ratio is a widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period.

Data Provider: Data is provided by Zacks Investment Research